nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Methotrexate—ankylosing spondylitis	0.894	1	CbGbCtD
Gadopentetate dimeglumine—Bradycardia—Prednisone—ankylosing spondylitis	0.000299	0.00283	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000296	0.0028	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000295	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000294	0.00278	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Dexamethasone—ankylosing spondylitis	0.000294	0.00278	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Betamethasone—ankylosing spondylitis	0.000294	0.00278	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Triamcinolone—ankylosing spondylitis	0.000292	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000291	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Triamcinolone—ankylosing spondylitis	0.00029	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000289	0.00274	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000289	0.00273	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000287	0.00272	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000284	0.00269	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000284	0.00269	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisolone—ankylosing spondylitis	0.000282	0.00267	CcSEcCtD
Gadopentetate dimeglumine—Cough—Triamcinolone—ankylosing spondylitis	0.000282	0.00267	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00028	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00028	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00028	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000279	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000279	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000278	0.00263	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000275	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Prednisone—ankylosing spondylitis	0.000274	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000274	0.00259	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000273	0.00259	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000273	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Prednisone—ankylosing spondylitis	0.000273	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000269	0.00255	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Methotrexate—ankylosing spondylitis	0.000269	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Betamethasone—ankylosing spondylitis	0.000268	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000268	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Prednisone—ankylosing spondylitis	0.000266	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000266	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000266	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000265	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Dexamethasone—ankylosing spondylitis	0.000265	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Betamethasone—ankylosing spondylitis	0.000265	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000264	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000263	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Betamethasone—ankylosing spondylitis	0.000263	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Dexamethasone—ankylosing spondylitis	0.000263	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000262	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Methotrexate—ankylosing spondylitis	0.000262	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Shock—Triamcinolone—ankylosing spondylitis	0.00026	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Shock—Methylprednisolone—ankylosing spondylitis	0.000259	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000259	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000258	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000258	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000258	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000258	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000258	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Prednisone—ankylosing spondylitis	0.000257	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000257	0.00243	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000256	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Prednisone—ankylosing spondylitis	0.000256	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000255	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000255	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000254	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Betamethasone—ankylosing spondylitis	0.000254	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000253	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Betamethasone—ankylosing spondylitis	0.000253	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000249	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Betamethasone—ankylosing spondylitis	0.000249	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000246	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Pain—Prednisolone—ankylosing spondylitis	0.000245	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000242	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000241	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000241	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00024	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00024	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00024	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000237	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000237	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000237	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000236	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Shock—Betamethasone—ankylosing spondylitis	0.000236	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Shock—Dexamethasone—ankylosing spondylitis	0.000236	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000235	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000235	0.00222	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000235	0.00222	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Prednisone—ankylosing spondylitis	0.000235	0.00222	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000234	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000234	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Prednisone—ankylosing spondylitis	0.000234	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000232	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000232	0.00219	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000232	0.00219	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Prednisone—ankylosing spondylitis	0.000231	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000229	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Prednisone—ankylosing spondylitis	0.000229	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000229	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Betamethasone—ankylosing spondylitis	0.000228	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000228	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisolone—ankylosing spondylitis	0.000228	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000228	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000228	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000227	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Pain—Triamcinolone—ankylosing spondylitis	0.000226	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000225	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Betamethasone—ankylosing spondylitis	0.000224	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000224	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000223	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000222	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Prednisone—ankylosing spondylitis	0.000221	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000221	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Prednisone—ankylosing spondylitis	0.000221	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Chills—Methotrexate—ankylosing spondylitis	0.00022	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000218	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000218	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Prednisone—ankylosing spondylitis	0.000218	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000218	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000217	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Prednisone—ankylosing spondylitis	0.000217	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000216	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000215	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000215	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000215	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000215	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Methotrexate—ankylosing spondylitis	0.000214	0.00202	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000212	0.002	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00021	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000209	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000209	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000209	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000209	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000208	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000208	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000208	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000207	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000207	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Methotrexate—ankylosing spondylitis	0.000207	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000207	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Betamethasone—ankylosing spondylitis	0.000207	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisone—ankylosing spondylitis	0.000205	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Pain—Dexamethasone—ankylosing spondylitis	0.000205	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Pain—Betamethasone—ankylosing spondylitis	0.000205	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000205	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisone—ankylosing spondylitis	0.000204	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Prednisone—ankylosing spondylitis	0.000203	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000202	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Prednisone—ankylosing spondylitis	0.000199	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000197	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000197	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000196	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000196	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000195	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000194	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methotrexate—ankylosing spondylitis	0.000193	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00019	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Betamethasone—ankylosing spondylitis	0.00019	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00019	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisolone—ankylosing spondylitis	0.00019	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000189	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000187	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000187	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Cough—Methotrexate—ankylosing spondylitis	0.000186	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000186	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methotrexate—ankylosing spondylitis	0.000185	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000182	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Methotrexate—ankylosing spondylitis	0.000182	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000181	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisolone—ankylosing spondylitis	0.000181	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000181	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000181	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00018	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Prednisone—ankylosing spondylitis	0.00018	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisolone—ankylosing spondylitis	0.00018	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Prednisone—ankylosing spondylitis	0.000178	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Methotrexate—ankylosing spondylitis	0.000176	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000175	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000174	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000174	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000172	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000172	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Betamethasone—ankylosing spondylitis	0.000172	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000171	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000171	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisolone—ankylosing spondylitis	0.000171	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Betamethasone—ankylosing spondylitis	0.000169	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000169	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000169	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000169	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000168	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000167	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Rash—Triamcinolone—ankylosing spondylitis	0.000166	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000166	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Methotrexate—ankylosing spondylitis	0.000166	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methylprednisolone—ankylosing spondylitis	0.000166	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000166	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisone—ankylosing spondylitis	0.000166	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Headache—Triamcinolone—ankylosing spondylitis	0.000165	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methylprednisolone—ankylosing spondylitis	0.000165	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000165	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000165	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000164	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000164	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methotrexate—ankylosing spondylitis	0.000163	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000159	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Betamethasone—ankylosing spondylitis	0.000158	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000158	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Triamcinolone—ankylosing spondylitis	0.000157	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000157	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000156	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000155	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Methotrexate—ankylosing spondylitis	0.000155	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000154	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000152	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Betamethasone—ankylosing spondylitis	0.000152	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000152	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Rash—Betamethasone—ankylosing spondylitis	0.000151	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dexamethasone—ankylosing spondylitis	0.000151	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000151	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000151	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000151	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methotrexate—ankylosing spondylitis	0.00015	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Headache—Dexamethasone—ankylosing spondylitis	0.00015	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Headache—Betamethasone—ankylosing spondylitis	0.00015	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Prednisone—ankylosing spondylitis	0.00015	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Pain—Methotrexate—ankylosing spondylitis	0.000149	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Prednisone—ankylosing spondylitis	0.000148	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000144	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000143	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000143	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dexamethasone—ankylosing spondylitis	0.000142	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Betamethasone—ankylosing spondylitis	0.000142	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methotrexate—ankylosing spondylitis	0.000139	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisone—ankylosing spondylitis	0.000138	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000138	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000138	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Prednisone—ankylosing spondylitis	0.000133	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisone—ankylosing spondylitis	0.000132	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisone—ankylosing spondylitis	0.000131	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisone—ankylosing spondylitis	0.000131	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000128	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Methotrexate—ankylosing spondylitis	0.000125	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisone—ankylosing spondylitis	0.000124	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methotrexate—ankylosing spondylitis	0.000123	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000119	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methotrexate—ankylosing spondylitis	0.000115	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methotrexate—ankylosing spondylitis	0.000111	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methotrexate—ankylosing spondylitis	0.00011	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00011	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methotrexate—ankylosing spondylitis	0.000109	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methotrexate—ankylosing spondylitis	0.000104	0.000981	CcSEcCtD
